Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Title
Intervention Indication Therapeutic Area Year Actions
Fosdenopterin for molybdenum cofactor
deficiency type A
Fosdenopterin Molybdenum cofactor deficiency Type A Endocrine Nutritional and Metabolic Disorders 2023 View  |  Download
Favezelimab-Pembrolizumab for treating relapsed or refractory classical Hodgkin Lymphoma after 2 or more therapies Favezelimab-pembrolizumab Hodgkin lymphoma Haematological Cancer and Lymphomas 2023 View  |  Download
Favezelimab-pembrolizumab for treating metastatic PD-L1 positive colorectal cancer Favezelimab-pembrolizumab Colorectal cancer Gastrointestinal Cancer , Oncology 2023 View  |  Download
Evolocumab for preventing major cardiovascular events in adults with a high risk of cardiovascular events Evolocumab Cardiovascular events Cardiovascular System 2023 View  |  Download
Evobrutinib for treating relapsing multiple sclerosis Evobrutinib Multiple sclerosis (MS) Neurology 2023 View  |  Download
Eplontersen for hereditary transthyretin-mediated amyloid polyneuropathy Eplontersen (ION-682884;AKCEA TTR-LRx) Transthyretin-mediated amyloid polyneuropathy Genetic Disorders 2023 View  |  Download
Epcoritamab for treating relapsed or refractory follicular lymphoma Epcoritamab (GEN-3013) Follicular lymphoma Haematological Cancer and Lymphomas 2023 View  |  Download
Enfortumab vedotin with pembrolizumab for treating bladder cancer Enfortumab vedotin (ASG-22ME; Padcev) , Pembrolizumab (Keytruda; MK-3475) Bladder cancer Urological Cancer 2023 View  |  Download
Encorafenib with binimetinib for treating metastatic BRAF V600 mutant non-small-cell lung cancer Binimetinib (MEK162; MEK-162; ARRY-162) , Encorafenib (LGX818) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Elinzanetant for the treatment of moderate to severe vasomotor symptoms (hot flashes) associated with the menopause Elinzanetant Post-menopausal vasomotor symptoms Women's Health 2023 View  |  Download
1 2 11 12 13 14 15 18 19
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications